CEL-SCI Appoints Mario Gobbo to Its Board of Directors

11d ago, source:

VIENNA, Va., April 23, 2024 -- ( BUSINESS WIRE )--CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of ...

CVM CEL-SCI Corporation

1d ago, source: Seeking Alpha

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States.

Why Is Cancer Focused CEL-SCI Stock Trading Higher Today?

5mon ago, source: Hosted on MSN

CEL-SCI Corporation (AMEX: CVM) announced that the British National Institute for Health and Care Excellence (NICE) has selected Multikine (Leukocyte Interleukin, Injection) to be evaluated as the ...

CEL-SCI Corporation

4mon ago, source: CNN

CEL-SCI Corp. is a biotechnology company, which engages in the research, development and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases.

CEL-SCI Corp CVM

24d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CEL-SCI Corp (LSRM.BE)

1mon ago, source: Yahoo Finance

VIENNA, Va., March 06, 2024--CEL-SCI Corporation issues letter to shareholders. VIENNA, Va., February 15, 2024--CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results.

CEL-SCI Corporation (CVM)

4d ago, source: Yahoo Finance

VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology. VIENNA, Va., February 13, 2024--CEL-SCI ...

CEL-SCI Corp CVM

16d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CEL-SCI Corporation (CVM)

12d ago, source: Yahoo Finance

VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology. VIENNA, Va., March 06, 2024--CEL-SCI Corporation ...